For instance, TRIM22 was found to inhibit osteosarcoma progression via destabilizing NRF2, which subsequently resulted in the imbalance of intracellular reactive oxygen species (ROS) and further activation of AMPK/mTOR/autophagy signaling [32]. This evidence concerns the gene MTOR and osteosarcoma.